Cooper Companies, Inc. (COO)

The Cooper Companies' stock experienced a notable decline of 36.86% from October 2, 2024, to October 1, 2025. In Q1 2025, CooperCompanies reported revenue of $964.7 million, up 4% year-over-year, and non-GAAP diluted EPS of $0.92, exceeding expectations, and raised its fiscal year 2025 non-GAAP diluted EPS guidance. In Q2 2025, the company announced revenue increased 6% year-over-year to $1,002.3 million and non-GAAP diluted EPS of $0.96, surpassing analyst estimates, and raised its 2025 profit forecast. Several analysts adjusted their ratings and price targets in July and August 2025. CEO Albert G. White III purchased 10,000 shares of the company's stock on September 5, 2025. CooperCompanies announced a $1 billion increase to its share repurchase program on September 17, 2025. Goldman Sachs initiated coverage on Cooper Companies with a "Sell" rating and a price target of $64.00 on October 1, 2025. As of October 4, 2025, the stock was up 1.9%, and in the week leading up to October 5, 2025, COO stock had risen by 5.24%, and by 6.35% over the previous month.

Specific detailed information regarding the seasonality of demand for The Cooper Companies' primary product lines is not explicitly detailed in the provided search results. Contact lenses may experience relatively stable demand throughout the year, though there could be minor fluctuations related to back-to-school periods or insurance benefit cycles. The company's focus on essential medical devices and ongoing healthcare needs suggests a generally consistent demand, though specific product categories might have subtle seasonal variations not explicitly stated.

The Cooper Companies, Inc. is a global medical device company based in San Ramon, California, operating in the Healthcare sector, specifically in the Ophthalmic Goods and Medical Devices industries. It has two primary business units: CooperVision (CVI), which focuses on contact lenses, and CooperSurgical (CSI), which is dedicated to women's health and fertility.

The Cooper Companies has a significant global presence, operating in over 130 countries across Europe, Asia, Africa, and the Americas. The company maintains a network of manufacturing, cryostorage, research and development (R&D), and distribution facilities worldwide. CooperVision's products are primarily manufactured in facilities located in the United Kingdom, Puerto Rico, Hungary, Costa Rica, and New York.

The Cooper Companies generally maintains a strong brand reputation, particularly through its CooperVision segment, which is recognized as a global leader in contact lenses. CooperCompanies has also highlighted its focus on sustainability, participating in the 2nd Annual Climate & Sustainability Leadership Forum and announcing sustainability goals for CooperVision, including reducing carbon emissions and increasing the use of renewable energy. There were no readily available reports of significant negative events impacting The Cooper Cos., Inc.'s brand reputation within the past year.

The Cooper Companies, Inc. is primarily owned by institutional investors, who hold approximately 101.25% of the total shares outstanding. Major institutional owners include Vanguard Group Inc, BlackRock, Inc., and State Street Corp. Insider ownership accounts for approximately 0.53% of the shares, and CEO Albert G. White III directly owned 226,151 shares as of September 5, 2025.